Industry recognition. See more on the awards page.
At ICON, we are at the forefront of innovation in clinical research, harnessing the power of Artificial Intelligence to transform the way trials are conducted.
Our AI solutions are designed to accelerate trial timelines, improve data accuracy, optimise resource management, and ensure compliance—all while maintaining the highest ethical standards. With our AI-driven approach, we are committed to delivering faster, smarter, and more reliable outcomes that benefit sponsors, patients, and healthcare providers for a healthier world.
AI champions
Our AI literacy program and network of AI Champions identify areas for greater efficiencies within the organisation.
Data scientists and engineers
Data scientists and engineers drive robust strategies, testing, development and impactful solutions.
Award-winning solutions
Multi-award winning innovative and pragmatic solutions delivering measurable and impactful value to our clients.
Our AI solutions
To provide a comprehensive understanding of our AI capabilities, we ve categorised our solutions into three main areas.
Accelerating trial execution
Our solutions in this category focus on streamlining the clinical trial process, from site selection to patient enrolment and study startup. These tools significantly reduce trial timelines and improve overall trial performance.
One Search
Identify the right sites and investigators faster, reducing time to site identification and improving patient recruitment success rates.
ICONex
Quickly identify key opinion leaders in all therapeutic areas including rare diseases, accelerating study design and startup.
Cassandra
Predict post-marketing study requirements early, allowing for proactive planning and reducing the risk of regulatory delays.
Enhancing data and resource management
These solutions are designed to improve the quality and efficiency of data management and resource allocation, ensuring that clinical trials run smoothly and effectively.
iSubmit
Automate document management for clinical trials, ensuring compliance and reducing the burden on study teams.
MRT COA
Stay updated with the latest clinical outcome assessments, providing comprehensive intelligence to optimise trial designs.
FORWARD+
Optimise your resource management with precise forecasting, targeted information and seamless automation.
Optimising operational efficiency
Our operational efficiency solutions are designed to transform the way teams interact with data and streamline critical processes, leading to faster and more informed decision making.
SmartDraft
Use AI to streamline site contract drafting, reduce negotiation cycles and accelerate site activation.
OMR AI Navigation Assistant
Gain quick, actionable insights from complex operational metrics with AI powered natural language queries.
Why choose AI at ICON?
-
proven results
Our AI solutions have been recognised with industry awards and have consistently delivered measurable improvements in trial performance. -
governance
We prioritise responsible AI use, backed by our AI Ethics Committee, ensuring that our solutions adhere to the highest standards of data privacy and security. -
innovation
We are continually pushing the boundaries of what's possible in clinical research to make trials more efficient, safe and insightful.
AI ethics committee
Our AI ethics committee ensures ICON is fully compliant and that we act ethically and with integrity. We will continue to provide the highest standard of data quality and protect and preserve our stakeholders’ individual privacy, confidentiality, and intellectual property rights.
AI at ICON insights and media contributions
Featured whitepapers
Integrating AI into clinical research: How AI is being used to enhance clinical development
AI is transforming clinical research – making drug development faster, more efficient, and more precise. ICON’s latest whitepaper explores how AI is already being integrated into clinical operations, featuring insights from the 2024 Citeline Survey and global research from Tufts CSDD and DIA.
Digital Disruption: Surveying the industry’s evolving landscape
The clinical research industry is embracing innovation to enhance safety, efficiency, and R&D returns, but digital disruption is progressing slower than expected. Our whitepaper analyses survey findings alongside 2019 results to uncover key factors influencing the adoption of advanced technologies like big data and AI.
Advancements in Artificial Intelligence for site selection
By harnessing the combined power of human expertise and AI technology, One Search delivers significant improvements across all key metrics, including recruitment rates, site identification speed, and compliance with project timelines.
.jpg?crop=yes&w=1430&h=750&a=5,0&itok=ZPMtBk33 "whitepaper_navigating real world healthcare data integr_thumbnail_Home Page Banner 1440 x 750 (1)"){kind=icon}
Beyond the token: Why real-world healthcare data and integration strategy matters
This whitepaper explores the challenges and opportunities arising from the proliferation of healthcare data, emphasising the need for robust data integration strategies to leverage this data effectively.
Applying AI to manage the risks and costs of postmarketing requirements
Our Cassandra AI system harnesses RWD on drugs and data obtained from the US FDA and EMA postmarketing requirements databases to accurately forecast whether postmarketing studies will be necessary.
-
Media article: Will big tech dominate healthcare in the years ahead?
Louisa Roberts, VP of Corporate Development and Partnerships, considers the benefits of partnerships with tech companies.
-
Media article: The path to smarter digital health
Michael Phillips and Kevin Rooney discuss the use of artificial intelligence for the purposes of automation in digital health and pharma.
-
Media article: Data Science: transforming the future of clinical trials
Machine learning and artificial intelligence have the potential to add much value to a clinical trial by facilitating informed decision-making, reducing the time to complete the trial, and the overall drug development process.
-
Media article: AI in Life Sciences – Covid pushes AI driven clinical trials and drug manufacturing into the limelight
In analyzing clinical trials and drug manufacturing, it is apparent that adoption of AI and machine learning technology holds astonishing potential to improve the healthcare sector.
-
Media article: Role of data in revolutionising the CRO industry
Tom O’Leary, chief information officer (CIO) of ICON, highlights how data is already revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
-
Media article: Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
AI and machine learning has been put into a position to transform the pharma landscape.
-
Media article: The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
An article featuring commentary by Andrew Garrett, discussing the importance of navigating through the hype surrounding AI and the ways in which the Pharma industry can manage expectations.
-
Media article: The Danger of 'Going too far' with AI
Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time.
Get started with AI at ICON
Ready to transform your clinical trials with AI? Contact us today to learn how ICON's AI solutions can accelerate your research and deliver better outcomes.